Vitreoretinopathy, Proliferative
"Vitreoretinopathy, Proliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Descriptor ID |
D018630
|
| MeSH Number(s) |
C11.768.890
|
| Concept/Terms |
Vitreoretinopathy, Proliferative- Vitreoretinopathy, Proliferative
- Proliferative Vitreoretinopathies
- Vitreoretinopathies, Proliferative
- Vitreoretinopathy Neovascular Inflammatory
- Inflammatories, Vitreoretinopathy Neovascular
- Inflammatory, Vitreoretinopathy Neovascular
- Neovascular Inflammatories, Vitreoretinopathy
- Neovascular Inflammatory, Vitreoretinopathy
- Vitreoretinopathy Neovascular Inflammatories
- Proliferative Vitreoretinopathy
|
Below are MeSH descriptors whose meaning is more general than "Vitreoretinopathy, Proliferative".
Below are MeSH descriptors whose meaning is more specific than "Vitreoretinopathy, Proliferative".
This graph shows the total number of publications written about "Vitreoretinopathy, Proliferative" by people in this website by year, and whether "Vitreoretinopathy, Proliferative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitreoretinopathy, Proliferative" by people in Profiles.
-
Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2020 05 11; 61(5):22.
-
Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy. Am J Ophthalmol. 2017 Apr; 176:194-202.
-
Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care. Fundam Clin Pharmacol. 2012 Oct; 26(5):644-78.